We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+9.97%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$362B
AUM Growth
+$48.6B
Cap. Flow
+$23.7B
Cap. Flow %
6.57%
Top 10 Hldgs %
15.39%
Holding
4,131
New
280
Increased
2,171
Reduced
1,370
Closed
179

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$958M
2
QCOM icon
Qualcomm
QCOM
+$865M
3
MS icon
Morgan Stanley
MS
+$739M
4
MSFT icon
Microsoft
MSFT
+$596M
5
V icon
Visa
V
+$444M

Sector Composition

Rank Sector Weight
1 Technology 24.33%
2 Financials 11.36%
3 Healthcare 11.13%
4 Consumer Discretionary 8.59%
5 Industrials 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OGI
3851
Organigram Holdings
OGI
$131M
$36K ﹤0.01%
5,173
+625
+14% +$5.31K
TOON icon
3852
Kartoon Studios
TOON
$34M
$35K ﹤0.01%
3,304
+14
+0.4% +$183
IMDX
3853
Insight Molecular Diagnostics
IMDX
$141M
$30K ﹤0.01%
684
-5
-0.7% -$288
ASMB icon
3854
Assembly Biosciences
ASMB
$498M
$28K ﹤0.01%
1,015
-204
-17% -$6.69K
AKBA icon
3855
Akebia Therapeutics
AKBA
$338M
$24K ﹤0.01%
10,549
-4,748
-31% -$12.9K
ASAP
3856
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$24K ﹤0.01%
1,603
GORO icon
3857
Goldgroup Mining Inc.
GORO
$155M
$23K ﹤0.01%
+15,023
New +$27.3K
UAVS icon
3858
AgEagle Aerial Systems
UAVS
$39.5M
$23K ﹤0.01%
15
-11
-42% -$26.7K
YARW
3859
Yarrow Bioscience, Inc. Common Stock
YARW
$20.3M
$22K ﹤0.01%
24
-12
-33% -$12.9K
KUST
3860
Kustom Entertainment Inc
KUST
$677K
0
CRBP icon
3861
Corbus Pharmaceuticals
CRBP
$165M
$19K ﹤0.01%
1,025
+543
+113% +$14.7K
GERN icon
3862
Geron
GERN
$898M
$17K ﹤0.01%
13,580
+1,020
+8% +$1.46K
REVBW icon
3863
Revelation Biosciences Warrant
REVBW
$8.64K
$16K ﹤0.01%
+22,886
New +$14K
SEEL
3864
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$16K ﹤0.01%
3
BNL icon
3865
Broadstone Net Lease
BNL
$4.25B
$13K ﹤0.01%
27,647
-15,575
-36% -$398K
TTOO
3866
DELISTED
T2 Biosystems, Inc
TTOO
$13K ﹤0.01%
5
-32
-86% -$111K
TRVN
3867
DELISTED
Trevena, Inc.
TRVN
$12K ﹤0.01%
32
-63
-66% -$34.9K
CARM
3868
DELISTED
Carisma Therapeutics
CARM
$11K ﹤0.01%
685
-8,892
-93% -$179K
BRMK.WS
3869
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$11K ﹤0.01%
128,500
PROCW
3870
DELISTED
Procaps Group, S.A. Warrants
PROCW
$10K ﹤0.01%
12,000
-3,000
-20% -$2.92K
TBLTW
3871
DELISTED
ToughBuilt Industries, Inc. Warrant
TBLTW
$10K ﹤0.01%
75,000
ADILW
3872
DELISTED
Adial Pharmaceuticals Warrant
ADILW
$10K ﹤0.01%
15,000
RNWK
3873
DELISTED
RealNetworks Inc
RNWK
$10K ﹤0.01%
+10,679
New +$13.8K
AUMN
3874
DELISTED
Golden Minerals Company
AUMN
$9K ﹤0.01%
1,006
CASI
3875
DELISTED
CASI Pharmaceuticals
CASI
$8K ﹤0.01%
1,000

Similar funds

Ameriprise's Q4 2021 Portfolio in Review

As of Q4 2021, Ameriprise held 4,131 positions worth $362B, up 16% from $313B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Ameriprise deployed $23.7B of net new capital in Q4 2021, opening 280 new positions and adding to 2,171 existing holdings. Its largest new stake was GlobalFoundries: 4,791,801 shares worth $311M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Fidelity National Information Services, an estimated $535M trimmed.

  • Ameriprise's largest Q4 2021 buy was GlobalFoundries: 4,791,801 shares worth $311M.
  • Ameriprise added most to Apple in Q4 2021, an estimated $958M increase.
  • Ameriprise's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $535M.
  • Ameriprise fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $59M.
  • Ameriprise's ten largest holdings make up 15% of its $362B portfolio in Q4 2021.
  • Ameriprise opened 280 new positions and closed 179 in Q4 2021.
  • Ameriprise's portfolio value rose 16% quarter-over-quarter to $362B.

Based on Ameriprise's 13F filing for Q4 2021, filed 14 Feb 2022.